• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED Back to Search Results
Model Number BA25-80/I16-40
Device Problems Failure To Adhere Or Bond (1031); Burst Container or Vessel (1074); Leak/Splash (1354)
Patient Problems Aneurysm (1708); Failure of Implant (1924); Pain (1994); Rupture (2208); No Code Available (3191)
Event Date 12/31/2016
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Devices remain implanted in the patient.
 
Event Description
It was reported that the patient had an initial procedure on (b)(6) 2013 with a bifurcated and suprarenal aortic extension.Subsequently, on (b)(6) 2016, the patient present to the hospital with a rupture and type 3a endoleak.Physician implanted a non-endologix graft to repair the issue.Patient is in stable condition.
 
Manufacturer Narrative
At the completion of the complaint investigation, based on the information received, the clinical evaluation was able to confirm; a type 3 endoleak between the main body and the proximal extension and an aneurysm rupture.There was also evidence to reasonable suggest the following observations; a type 1a endoleak, aneurysm sac growth, suboptimal overlap between the main body and proximal extension, and dilation of the main body stent.The clinical evaluation additionally identified the following potential contributing factors to the reported event; off label use due to patient anatomy, insufficient overlap between the main body and the proximal extension, and the patient's history of cardiac disease.The review of the manufacturing lot confirmed all devices met specifications prior to release.The event devices remain implanted in the patient and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key6284907
MDR Text Key65998591
Report Number2031527-2017-00047
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PO40002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2015
Device Model NumberBA25-80/I16-40
Device Lot Number1060064-011
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/28/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/14/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SUPRARENAL AORTO UNI-ILIAC - (B)(4)
Patient Outcome(s) Required Intervention;
Patient Age81 YR
-
-